Showing results (21-30 of 46) with videos related to

Sort By:
Pageof 5
European Journal of Cancer (Oxford, England : 1990)|October 9, 2013
Efficacy and safety of ipilimumab 3mg/kg in patients with pretreated, metastatic, mucosal melanomaMichele Del Vecchio, Lorenza Di Guardo, Paolo A Ascierto, et al.
Endocrine|July 7, 2021
Irinotecan-based chemotherapy in extrapulmonary neuroendocrine carcinomas: survival and safety data from a multicentric Italian experienceCamilla Bardasi, Andrea Spallanzani, Stefania Benatti, et al.
Tumori|July 7, 2023
Outcomes in patients with BRAFV600-mutated melanoma and brain metastases at baseline treated with dabrafenib plus trametinibMassimo Aglietta, Vanna Chiarion-Sileni, Paolo Fava, et al.
Targeted Oncology|November 10, 2021
Retrospective Chart Review of Dabrafenib Plus Trametinib in Patients with Metastatic BRAF V600-Mutant Melanoma Treated in the Individual Patient Program (DESCRIBE Italy)Massimo Aglietta, Vanna Chiarion-Sileni, Paolo Fava, et al.
Journal of Translational Medicine|June 3, 2014
Clinical experience with ipilimumab 3 mg/kg: real-world efficacy and safety data from an expanded access programme cohortPaolo A Ascierto, Ester Simeone, Vanna Chiarion Sileni, et al.
Journal of Geriatric Oncology|January 14, 2020
Anti-PD1 antibodies in patients aged ≥ 75 years with metastatic melanoma: A retrospective multicentre studyLaura Ridolfi, Francesco De Rosa, Elisabetta Petracci, et al.
Journal of Experimental & Clinical Cancer Research : CR|April 9, 2014
Efficacy and safety of ipilimumab in elderly patients with pretreated advanced melanoma treated at Italian centres through the expanded access programmeVanna Chiarion Sileni, Jacopo Pigozzo, Paolo Antonio Ascierto, et al.
Frontiers in Oncology|September 1, 2022
Comparison Between First Line Target Therapy and Immunotherapy in Different Prognostic Categories of BRAF Mutant Metastatic Melanoma Patients: An Italian Melanoma Intergroup StudyRiccardo Marconcini, Paolo Fava, Amedeo Nuzzo, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|January 24, 2018
Sunitinib in patients with pre-treated pancreatic neuroendocrine tumors: A real-world studyMaria Rinzivillo, Nicola Fazio, Sara Pusceddu, et al.
European Journal of Cancer (Oxford, England : 1990)|August 7, 2023
Italian nivolumab Expanded Access Programme in melanoma adjuvant setting: patient outcomes and safety profilePaolo A Ascierto, Anna M Di Giacomo, Vanna Chiarion Sileni, et al.
Pageof 5